Inmed PharmaceuticalsINM
13F holders, Q4 2024 (December 31)5holders
$4.64avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding Inmed Pharmaceuticals Inc. (INM) in their 13F filings. The largest holders were AdvisorShares Investments LLC ($177K), UBS Group AG ($49K) and Danske Bank A/S ($5).
- Company
- Inmed Pharmaceuticals Inc.
- CUSIP
- 457637700
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $227K |
| Exits | 0 | $0 |
Ownership 5 holders
| AdvisorShares Investments LLC | 0.03% | New | 38,460 | $177K |
| UBS Group AG | 0.00% | New | 10,408 | $49K |
| Danske Bank A/S | 0.00% | New | 1 | $5 |
| AllSquare Wealth Management LLC | 0.00% | New | 1 | $5 |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 1 | $5 |
"% of holder's portfolio" is INM's weight in each manager's 13F, not the share of Inmed Pharmaceuticals Inc. the manager owns.